News icon  PreviPharma News

PreviPharma COVID-19 Statement

March 27th, 2020

In the current global situation caused by COVID-19, PreviPharma is committed to keeping you informed of our actions to provide important services to our global customers and partners. Read more


PreviPharma Announces Research Collaboration with Global Biotherapeutics Leader CSL Behring

September 23rd, 2019

PreviPharma today announces the start of a research collaboration with global biotherapeutics leader CSL Behring to develop a novel plasma protein-based drug for severely ill patients suffering from diseases with unmet medical needs.